Key result
Higher baseline PNI linked to ~15% lower mortality per unit in elderly CTO-PCI patients.
Why the study?
The study aimed to evaluate the association between the prognostic nutritional index and long-term all-cause mortality and MACEs in elderly patients with chronic total occlusion following successful PCI.
Is baseline prognostic nutritional index associated with long-term all-cause mortality and MACE in elderly patients with chronic total occlusion after successful percutaneous coronary intervention?
Cohort (n=745)
No
Is baseline prognostic nutritional index associated with long-term all-cause mortality and MACE in elderly patients with chronic total occlusion after successful percutaneous coronary intervention?
Hazard Ratio: 0.85 (95% CI 0.81–0.9)
p-value: p=<0.001
Lower baseline prognostic nutritional index is independently associated with higher risks of long-term all-cause mortality and MACE in elderly patients after successful CTO-PCI.
PNI may refine mortality risk stratification after CTO-PCI; hypothesis-generating for nutritional interventions in this population.
Background: This study aimed to investigate the association between the prognostic nutritional index (PNI) and long-term all-cause mortality and major adverse cardiovascular events (MACEs) in elderly patients with chronic total occlusion (CTO) after successful percutaneous coronary intervention (PCI). Methods: This retrospective study enrolled 745 consecutive patients aged ≥ 60 years with successfully revascularized CTO between February 2011 and April 2023. All-cause mortality was the primary endpoint. MACE, defined as the first occurrence of all-cause mortality, non-fatal myocardial infarction, stroke, or target-vessel revascularization (TVR), was the secondary endpoint. Cox proportional hazards models and restricted cubic spline (RCS) analyses were used to evaluate associations. Results: During a median follow-up of 813 days, 58 (7.8%) all-cause mortality and 101 (13.6%) MACE occurred. In the primary multivariable model (Model 2), each 1-unit increase in PNI was associated with a 15% reduced risk of all-cause mortality (HR 0.85, 95% CI 0.81–0.90; p < 0.001) and an 8% reduced risk of MACE (HR 0.92, 95% CI 0.88–0.96; p < 0.001). Compared with the T1 group, patients in the T2 group had a significantly lower risk of all-cause mortality (HR = 0.21, 95% CI: 0.10–0.44; p < 0.001) and MACE (HR = 0.38, 95% CI: 0.23–0.63; p = 0.002). Similarly, the T3 group showed a significantly lower risk of all-cause mortality (HR = 0.24, 95% CI: 0.11–0.52; p = 0.003) and MACE (HR = 0.49, 95% CI: 0.30–0.82; p = 0.007). These associations remained directionally consistent in exploratory models with more extensive covariate adjustment. RCS indicated a linear association between PNI and all-cause mortality (p = 0.959) and a nonlinear association with MACE (p = 0.017). Conclusion: In this single-center retrospective cohort of elderly patients after successful CTO-PCI, lower baseline PNI was associated with higher risks of all-cause mortality and MACE. PNI may be a useful risk stratification tool, but its clinical utility requires confirmation in prospective, externally validated studies before implementation.
No takes yet. Share an insight, caveat, or question.
Xiao et al. (2026) conducted a cohort in Chronic total occlusion (CTO) after successful percutaneous coronary intervention (PCI) (n=745). Prognostic nutritional index (PNI) vs. Lower PNI was evaluated on All-cause mortality (HR 0.85, 95% CI 0.81-0.90, p=<0.001). Each 1-unit increase in baseline Prognostic Nutritional Index was associated with a 15% reduced risk of all-cause mortality (HR 0.85) in elderly patients after successful CTO-PCI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: